Home » Topics » BioWorld Science

BioWorld Science
RSS

IL-2 partial agonist allows T-cell expansion without differentiation

Oct. 29, 2021

IACTA Pharmaceuticals receives funding to conduct preclinical studies of IC-800

Oct. 29, 2021

Novel AChE/GSK-3beta inhibitor shows promising activity in models of AD

Oct. 29, 2021

New PKP2-based gene therapy for ARVC treatment

Oct. 29, 2021

Bayer describes new anthelmintic compounds

Oct. 29, 2021

Camp Therapeutics identifies new antibacterial peptides

Oct. 29, 2021

Agios Pharmaceuticals, University of Michigan present menin/MLL interaction inhibitors

Oct. 29, 2021

New IL-17 modulators discovered at UCB

Oct. 29, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents HBV HBsAg secretion inhibitors

Oct. 29, 2021

Adding MGMT-modified gamma-delta T cells to temozolomide in models of high-grade gliomas

Oct. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...